Ali̇ İnal
Impact in
-
- Pancreatic and Hepatic Oncology Research
- Lung Cancer Research Studies
-
- Brain Metastases and Treatment
- Gastric Cancer Management and Outcomes
Papers in
- Oncology 28
- Colorectal Cancer Treatments and Studies 6
- Cancer Diagnosis and Treatment 5
- Pancreatic and Hepatic Oncology Research 5
-
- Brain Metastases and Treatment 5
- Gastric Cancer Management and Outcomes 5
- Lung Cancer Diagnosis and Treatment 5
- Co-authors
- Abdurrahman Işıkdoğan (33 shared papers)Kaplan Ma (27 shared papers)Zuhat Urakçı (22 shared papers)Mehmet Küçüköner (20 shared papers)Kenan Sağlam (2 shared papers)Abdullah Taşlıpınar (1 shared paper)Zeki Yeşilova (4 shared papers)Uğur Muşabak (6 shared papers)
- Journals
- Medical Oncology (2 papers)Hepatogastroenterology (2 papers)BMC Cancer (2 papers)Breast Cancer (2 papers)Tumor Biology (2 papers)
- Partner nations
- TürkiyeSerbiaUnited States
In The Last Decade
Ali̇ İnal
99 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 100
- Oncology 242
- Pulmonary and Respiratory Medicine 274
- Immunology 168
- Rheumatology 85
- Endocrinology, Diabetes and Metabolism 83
Countries citing papers authored by Ali̇ İnal
This map shows the geographic impact of Ali̇ İnal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ali̇ İnal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ali̇ İnal more than expected).
Fields of papers citing papers by Ali̇ İnal
This network shows the impact of papers produced by Ali̇ İnal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ali̇ İnal. The network helps show where Ali̇ İnal may publish in the future.
Co-authors
The 25 scholars most cited alongside Ali̇ İnal, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 103 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 98 | |
| 2 | 2013 | 67 | |
| 3 | 2011 | 57 | |
| 4 | 2004 | 56 | |
| 5 | 2004 | 55 | |
| 6 | 2004 | 48 | |
| 7 | 2004 | 41 | |
| 8 | 2003 | 36 | |
| 9 | 2011 | 30 | |
| 10 | 2013 | 28 | |
| 11 | 2013 | 26 | |
| 12 | 2002 | 26 | |
| 13 | 2008 | 25 | |
| 14 | 2012 | 23 | |
| 15 | 2013 | 23 | |
| 16 | 2012 | 23 | |
| 17 | 2006 | 22 | |
| 18 | 2012 | 21 | |
| 19 | 2005 | 20 | |
| 20 | Prognostic factors in patients with advanced pancreatic cancer treated with gemcitabine alone or gemcitabine plus cisplatin: retrospective analysis of a multicenter study. | 2012 | 19 |
About Ali̇ İnal
Ali̇ İnal is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Immunology and Endocrinology, Diabetes and Metabolism, having authored 103 papers that have together received 1.2k indexed citations. Recurring topics across this work include Inflammasome and immune disorders (7 papers), Colorectal Cancer Treatments and Studies (6 papers), Breast Cancer Treatment Studies (5 papers), Cancer Diagnosis and Treatment (5 papers), Brain Metastases and Treatment (5 papers), Pancreatic and Hepatic Oncology Research (5 papers), Gastric Cancer Management and Outcomes (5 papers) and Lung Cancer Diagnosis and Treatment (5 papers). The work is most often cited by research in Oncology (242 citations), Pulmonary and Respiratory Medicine (274 citations), Immunology (168 citations), Rheumatology (85 citations) and Endocrinology, Diabetes and Metabolism (83 citations). Ali̇ İnal has collaborated with scholars based in Türkiye, Serbia and United States. Frequent co-authors include Abdurrahman Işıkdoğan, Kaplan Ma, Zuhat Urakçı, Mehmet Küçüköner, Kenan Sağlam, Abdullah Taşlıpınar, Zeki Yeşilova, Uğur Muşabak, Ahmet Yekta Tüzün and Ahmet Rüçhan Akar. Their work appears in journals such as Medical Oncology, Hepatogastroenterology, BMC Cancer, Breast Cancer and Tumor Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.